Mr. Speaker, we have been very clear. If we want to move forward with the national pharmacare program, the first thing we have to do is lower drug prices. The first thing we did is that we are in the process of modernizing the Patented Medicine Prices Review Board. We have also joined the pan-Canadian pharmaceutical alliance, and so far we have saved billions of dollars because we are able to bulk-purchase drugs with other provinces and territories. Finally, we have launched the advisory council on the implementation of a national pharmacare program. I look forward to receiving its final report next month.
In the House of Commons on May 28th, 2019. See this statement in context.